RVL Pharmaceuticals plc Ord (OSMT) Fundamentals

Osmotica Pharmaceuticals PLC is a fully-integrated biopharmaceutical company. It is focused on developing, manufacturing and commercializing specialty products. The product portfolio of the group includes specialty neurology and women's health products, which are primarily complex formulations of generic drugs. Osmotica has a late-stage development pipeline by two NDA candidates that recently completed Phase III clinical trials: arbaclofen ER for spasticity in multiple sclerosis patients and RVL-1201 for the treatment of acquired blepharoptosis, or droopy eyelid.
SHARE INFORMATION
Market Cap$ 92,451,712
Shares Outstanding83,289,831
Float40,884,136
Percent Float49.09%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 177,884,000
Latest Fiscal EPS$ -1.31
Latest Fiscal Date2020-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions159
Institutional Holdings Date2021-12-31
Institutional Bought Previous 3 Months355,032
Institutional Holdings Percent6.2%
Institutional Sold Previous 3 Months3,381,209
Insider Holdings Date2021-12-31
Insider Bought Previous 3 Months1,675,186
Insider Holdings Percent3.9
Insider Sold Previous 3 Months-
Insider Shares Owned3,214,078
TRADING INFO
52 Week High$ 4.95
52 Week Low$ 0.98
52 Week High Change$ -74.48
21 Day Moving Average$ 1.0945
21 Day Extended Moving Average$ 1.1293
50 Day Moving Average$ 1.2869
50 Day Extended Moving Average$ 1.3567
200 Day Moving Average$ 2.5856
200 Day Extended Moving Average$ 2.5295
10 Day Average Volume398,004
20 Day Average Volume808,524
30 Day Average Volume684,961
50 Day Average Volume671,427
Alpha-0.054835
Beta1.9598
Standard Deviation0.245602
R20.172987
7 Day Price Change$ -0.03
7 Day Percent Change-2.63%
21 Day Price Change$ 0.05
21 Day Percent Change4.72%
30 Day Price Change$ 0.126
30 Day Percent Change12.8%
Month to Date Price Change$ 0.03
Month to Date Percent Change2.78%
Quarter to Date Price Change$ 0.03
Quarter to Date Percent Change2.78%
180 Day Price Change$ -2.11
180 Day Percent Change-65.53%
200 Day Price Change$ -1.75
200 Day Percent Change-61.19%
Year to Date Price Change$ 0.03
Year to Date Percent Change2.78%

RVL Pharmaceuticals plc Ord (OSMT) Key Ratios

PROFITABILITY
EBIT Margin-55.6%
EBITDA Margin-48.0%
Pre-Tax Profit Margin-59.8%
Profit Margin Count-76.49%
Gross Margin54.7%
Profit Margin TOT-65.44%
INCOME STATEMENTS
Revenue$ 14,641,000
Revenue Per Share$ 0.1758
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-3.30
Total Debt To Equity0.60
Int Coverage-7.30
Current Ratio0.40
Leverage Ratio3.80
Quick Ratio0.20
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 117,426,509
Price to Sales6.3146
Price to Free Cash-2.90
PE High Last 5 Years0.00
Price To Book1.70
Price To Cash Flow34.70
PE Low Last 5 Years0.00
Price to Tangible Book-3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.00
Invoice Turnover8.40
Assets Turnover0.10
Return Assets-37.67
Return on Equity-98.35
Return on Capital-39.53

RVL Pharmaceuticals plc Ord (OSMT) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOBrian A. Markison
Emplyoees302
Last AuditUQ
CIK0001739426
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address400 Crossing Boulevard
Bridgewater, NJ 8807
Websitehttps://www.osmotica.com
Facsimile+1 908 809-1301
Telephone+1 908 809-1300
Email-


Your Recent History
NASDAQ
OSMT
Osmotica P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.